Numinus Wellness (NUMI.TO) Stock Price

Numinus Wellness, Inc engages in the development of psychedelic-centered therapeutic products and services. The company is headquartered in Montreal, Quebec. The firm develops proprietary, psychedelic-centered, therapeutic products and services through its own laboratory and research and development processes. The firm operates through three segments: Clinical Research Operations, the Canadian Clinic Network, the U.S. Clinic Network. Its Research Operations is focused on licensed psychedelic research and provides clinical research management services to academic institutions and biotechnology companies. Numinus clinic network in Canada consists of Numinus Health, Mindspace, and the NCT. Numinus clinic network in the United States consists of Cedar Psychiatry Inc. (Cedar Psychiatry) and Foundations for Change Inc. (FFC). Numinus clinic network provides services including ketamine-assisted psychotherapy (KAP) for depression, transcranial magnetic stimulation (TMS), neurological care and psychotherapy and counselling by registered psychologists.